Objective To establish an HPLC-MS/MS method for determination of the content of citalopram in human plasma. Methods The chromatographic column was Agilent-ZORBAX-C8 (4.6×150 mm,5 μm), from Agilent Company, The mobile phase was methyl cyanides-0.1%formic acid(60∶〖KG-*2〗40). The flow rate was 0.5 ml/min and m/z 256.2167.1. The column temperature was 20 ℃. Electrospray ionization(ESI) source was applied and multi-reaction monitoring(MRM) mode with the transitions of m/z 325.1262.1(for citalopram) and m/z 256.2167.1 (for diphenhydramine internal standard)was used. Results The assay linearity of citalopram was confirmed over the range 0.5-100 ng/ml ( r =0.9979). The intra-and inter-day precision (RSD) was less than 10%. Conclusions The method is proved to be quick,specific,sensitive and accurate,which can be used for the determination of citalopram in plasma.
Key words
citalopram /
HPLC-MS/MS /
blood drug level
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1]玄桂红,刘龙发.西酞普兰治疗老年抑郁障碍临床观察[J].吉林医学,2010,31(7):952-953.
[2]郑艳,张录凤.西酞普兰与文拉法辛治疗抑郁症对照研究[J].中国民康医学,2008, 20(23):2762-2764.
[3]史周印,王艳,孙杰,等.西酞普兰对围化疗期癌症抑郁患者的临床疗效分析[J].现代防医学,2010,37(18):3564-3565.
[4]Zhang Y,Raap D K,Garcia F,et al.Long—term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats[J].Brain Res,2000,855(1):58-66.
[5]Raap D K,Vande Kar L D.Selective serotonin reuptake inhibitors and neuroendoerine func- tion[J].Iife Sci,1999,65(12):1217-1235.
[6]Duverneuil.A HPLC with photodiode—array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs[J].Ther Drug Monit,2003,25(5):565-573.
[7]Rodriguez T B,Dreher J,Malevany l,et al.Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients[J].Ther Drug Monit,2001,23(4):435-440.
[8]Matuszewski B K, Constanzer M L, Chavez C M. Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC-MS/MS[J]. Anal Chem, 2003, 75(13): 3019-3030.
[9]ZHONG D F. Some aspects in establishing standard curves in bioanalyses with weighted least squires method [J]. Chin J Pharm Anal,1996,16(5):343-346.
[10]郑志昌,Ulrich Klotz.西酞普兰及代谢物的对映体稳态血药浓度[J].贵阳医学院学报,2000,25(3):238-240.
[11]张永泰,张淑慧,汪玉梅,等. 人血浆中西酞普兰的HPLC一荧光法测定[J].中国医药工业杂志,2004,35(12):734-736.
[12]司徒冰,温预关. 人血浆中西酞普兰的HPLC一荧光法测定及其药物动力学[J]. 中国医药工业杂志,2005,36(6):352-354.
[13]赵忠琼,梁隆,朱群彬,等. HPLC法测定氢溴酸西酞普兰及其片剂含量和有关物质[J]. 药物分析杂志,2005,25(3):342-344.
[14]刘津爱,朱梅. 高效液相色谱法测定草酸艾司西酞普兰的手性杂质[J].药物鉴定,2011,20(7):18-19.
[15]石苇,温预关,陈孝.氢溴酸西酞普兰片在健康人体内的药动学[J].中国医院药学杂志,2009,29(20):1710-1712.